Pharmacokinetics and safety of a single intravenous dose of the antibiotic tigecycline in patients with cirrhosis.
Korth-Bradley
Joan M
JM
Clinical Pharmacology, Pfizer, 500 Arcola Road, Collegeville, PA 19426, USA. korthbj@wyeth.com
Baird-Bellaire
Susan J
SJ
Patat
Alain A
AA
Troy
Steven M
SM
Böhmer
Gabriele M
GM
Gleiter
Christoph H
CH
Buecheler
Reinhild
R
Morgan
Marsha Y
MY
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008103:Liver Cirrhosis / Q000150:complications* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D012720:Severity of Illness Index; D000078304:Tigecycline
D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline